Key Financial Data Of Group

Cyfuse Biomedical K.K. - Filing #7571308

Concept 2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2019-12-31
2019-01-01 to
2019-12-31
As at
2018-12-31
2018-01-01 to
2018-12-31
Key financial data of group
Business results of group
Net sales
374,477,000 JPY
708,245,000 JPY
137,484,000 JPY
121,810,000 JPY
26,123,000 JPY
Ordinary profit (loss)
-433,165,000 JPY
144,914,000 JPY
-327,492,000 JPY
-369,495,000 JPY
-383,622,000 JPY
Net assets
3,769,801,000 JPY
1,900,114,000 JPY
1,549,458,000 JPY
1,778,959,000 JPY
1,483,464,000 JPY
Total assets
4,815,337,000 JPY
2,646,232,000 JPY
2,196,213,000 JPY
2,037,902,000 JPY
1,750,418,000 JPY
Net assets per share
484.88
-5,183.91
-5,469.44
-2,405,548.48
-2,034,415.12
Basic earnings (loss) per share
-177.67
285.53
-658.34
-371,133.37
-385,245.79
Diluted earnings per share
Equity-to-asset ratio
0.783 xbrli:pure
0.718 xbrli:pure
0.705 xbrli:pure
0.872 xbrli:pure
0.847 xbrli:pure
Rate of return on equity
xbrli:pure
0.083 xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-403,596,000 JPY
161,537,000 JPY
-294,001,000 JPY
JPY
JPY
Net cash provided by (used in) investing activities
-430,674,000 JPY
-50,583,000 JPY
-264,000 JPY
JPY
JPY
Net cash provided by (used in) financing activities
2,658,538,000 JPY
229,206,000 JPY
488,905,000 JPY
JPY
JPY
Cash and cash equivalents
3,437,307,000 JPY
1,613,040,000 JPY
1,272,879,000 JPY
JPY
JPY
Number of employees
21 xbrli:pure
22 xbrli:pure
19 xbrli:pure
19 xbrli:pure
21 xbrli:pure
Average number of temporary employees
1 xbrli:pure
2 xbrli:pure
2 xbrli:pure
3 xbrli:pure
2 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.